V2X Shares Fall Following News of Secondary Offering
Shares of V2X were trading lower in the after-hours market following news of an underwritten public offering of 2 million shares by a selling stockholder.
From the Biotech Insider archive. This article dates from Sep 4, 2024 and is preserved as first published.
Shares of V2X were trading lower in the after-hours market following news of an underwritten public offering of 2 million shares by a selling stockholder.
The selling shareholder also plans to grant the underwriters an option to purchase up to 300,000 additional shares.
The selling shareholder also plans to grant the underwriters an option to purchase up to 300,000 additional shares.
After the bell, V2X’s shares were trading 7% lower at $49.60 per share. The stock finished Wednesday’s regular session with a loss of 2.1% at $53.35. Year to date, shares are up 14%.
The company, which provides solutions and support to defense clients, has 31.56 million shares outstanding and a public float of 12.07 million shares.
